Go to the list of all blogs
Scott Bell's Avatar
published in Blogs
Oct 27, 2026
TickeronGET DAILY SIGNALS
AptarGroup (ATR) vs Rush Street Interactive (RSI): Stability Against High-Growth Momentum

AptarGroup (ATR) vs Rush Street Interactive (RSI): Stability Against High-Growth Momentum

Key Takeaways

  • AptarGroup (ATR) is a diversified drug-delivery and consumer-dispensing leader, while Rush Street Interactive (RSI) is a fast-growing online casino and sports-betting operator — two very different risk-reward profiles.
  • ATR offers stability, a quarterly dividend, and steady but modest growth, yet it is navigating margin compression and pharma destocking headwinds.
  • RSI is delivering high double-digit revenue growth, record profitability, and a debt-free balance sheet, but it carries higher volatility and regulatory exposure.
  • Relative performance has diverged sharply: RSI has generated a strong trailing one-year return, while ATR shares have declined over the past year.
  • Market sentiment currently leans more constructive on RSI's growth trajectory, whereas ATR is viewed as a defensive, cash-returning compounder.
  • Get more detail on each name's latest headlines and intraday moves: ATR Major News and ATR Today's Price Move, plus RSI Major News and RSI Today's Price Move.
  • For automated, data-driven ideas across the market, explore the curated Trending AI Robots.

Setting the Scene

Investors weighing these two stocks are effectively choosing between a mature industrial-healthcare franchise and a high-growth consumer technology company. ATR, AptarGroup, supplies dispensing and drug-delivery systems used by pharmaceutical and consumer brands worldwide. RSI, Rush Street Interactive, operates online casino and sports-betting platforms across North and Latin America. The comparison is relevant to traders assessing momentum and growth potential, as well as longer-term investors evaluating earnings stability, cash returns, and sector risk. Their divergent business models, growth rates, and recent market behavior make this an instructive head-to-head study in market positioning and relative performance.

AptarGroup (ATR) Overview and Recent Performance

AptarGroup is a global leader in drug-delivery, dosing, and protection technologies, serving pharmaceutical, beauty, food-and-beverage, and personal-care markets from more than 20 countries. Its three segments — Pharma, Beauty, and Closures — provide broad diversification. In recent quarters, the company reported record revenue exceeding $1 billion, driven by strength in injectables, biologics, and GLP-1-related therapies, as well as consumer healthcare applications such as nasal decongestants and eye-care solutions. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

However, recent market activity has been characterized by margin compression. Adjusted EBITDA margins declined as emergency-medicine destocking weighed on prescription sales, while higher input costs and temporary operational issues pressured the Beauty and Closures segments. Management has guided to improving margins as destocking abates, and the company continues returning capital through a quarterly dividend and share repurchases. Still, shares have declined over the past year, and the stock has underperformed its broader industry.

Rush Street Interactive (RSI) Overview and Recent Performance

Rush Street Interactive is an online casino and sports-betting company operating in the United States, Canada, and Latin America, with a "casino-first" strategy in which online casino represents the majority of revenue. Recent results have been notably strong: quarterly revenue rose roughly 46% year over year to a record, adjusted EBITDA climbed about 61%, and monthly active users (MAUs) increased by more than 50%. The company has raised its full-year guidance, and it launched operations in Alberta during the recent period.

Growth is being fueled by market-share gains in North American iGaming, expansion in Latin America, and a favorable World Cup-driven period, alongside a debt-free balance sheet and an active share-buyback program. At the same time, the stock has been volatile, pulling back notably over the past month despite a strong year-to-date advance. Regulatory and tax developments in markets such as Colombia, along with rising marketing spend, remain key variables that could influence profitability and sentiment going forward.

Head-to-Head Comparison

The most fundamental contrast is business model. ATR is an industrial manufacturer with recurring demand tied to pharmaceutical consumption and consumer products; it grows steadily but is exposed to input costs, product mix, and destocking cycles. RSI is a digital consumer platform whose revenue is tied to player engagement, market access, and regulatory outcomes; it grows far faster but with higher volatility and geographic concentration risk.

On growth, the gap is wide — RSI's revenue has been expanding at a double-digit pace, while ATR's growth is more modest and recently constrained by margin pressure. On stability, the advantage reverses: ATR generates consistent cash flow, pays a dividend, and has decades of operating history, whereas RSI reinvests heavily in marketing and faces evolving gaming regulations and taxes. From a market-sentiment standpoint, RSI carries stronger upward momentum and a more bullish analyst posture, but with a recent sharp pullback. ATR, by contrast, is viewed more defensively, supported by share repurchases and a long-term pharma growth target in the high single-digit to low double-digit range.

AI-Driven Perspective

Based on observable factors — trend consistency, momentum, catalysts, and relative positioning — Tickeron's AI would likely tilt toward RSI for traders prioritizing growth and price momentum, given its accelerating revenue, record profitability, and upward guidance revisions. However, that preference would come with recognition of RSI's higher volatility and regulatory risk. For stability-oriented or risk-averse profiles, the AI might favor ATR's steadier cash generation, dividend, and diversified end markets, particularly as near-term destocking headwinds begin to ease. The verdict is probabilistic rather than definitive: momentum currently appears stronger in RSI, while durability and downside resilience appear stronger in ATR.

Using Tickeron’s Trending AI Robots for Deeper Insights

In my research process, I often turn to Tickeron’s Trending AI Robots to review how algorithmic strategies are performing across names like these. The page highlights only the best-performing and most market-appropriate AI trading bots, each with its own trading style, strategy, timeframe, performance history, and set of covered symbols. Because market conditions change constantly, the bots featured are those judged most suitable for the current environment. Exploring the page lets traders review bot statistics, strategies, and track records side by side, providing a convenient starting point for applying algorithmic analysis to stocks such as ATR and RSI.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: ATR, RSI

Contributor

Scott Bell's AvatarScott Bell|Expert

I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking


Momentum Indicator for ATR turns negative, indicating new downward trend

ATR saw its Momentum Indicator move below the 0 level on November 16, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 83 similar instances where the indicator turned negative. In 43 of the 83 cases, the stock moved further down in the following days. The odds of a decline are at 52%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for ATR moved out of overbought territory on November 11, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 similar instances where the indicator moved out of overbought territory. In 10 of the 33 cases, the stock moved lower in the following days. This puts the odds of a move lower at 30%.

The Moving Average Convergence Divergence Histogram (MACD) for ATR turned negative on November 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 60 similar instances when the indicator turned negative. In 21 of the 60 cases the stock turned lower in the days that followed. This puts the odds of success at 35%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ATR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 50%.

ATR broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 34 of 58 cases where ATR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 59%.

ATR moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ATR crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 60%.

The 50-day moving average for ATR moved above the 200-day moving average on November 10, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a +1.02% 3-day Advance, the price is estimated to grow further. Considering data from situations where ATR advanced for three days, in 181 of 332 cases, the price rose further within the following month. The odds of a continued upward trend are 55%.

The Aroon Indicator entered an Uptrend today. In 112 of 222 cases where ATR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 50%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. ATR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 59 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 72 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ATR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Valuation Rating of 73 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.447) is normal, around the industry mean (4.964). P/E Ratio (25.446) is within average values for comparable stocks, (40.591). Projected Growth (PEG Ratio) (2.595) is also within normal values, averaging (4.143). Dividend Yield (0.014) settles around the average of (0.006) among similar stocks. P/S Ratio (2.072) is also within normal values, averaging (56.876).

Notable companies

The most notable companies in this group are Intuitive Surgical (NASDAQ:ISRG), Align Technology (NASDAQ:ALGN).

Industry description

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

Market Cap

The average market capitalization across the Pharmaceuticals: Other Industry is 9.78B. The market cap for tickers in the group ranges from 126 to 159.96B. ISRG holds the highest valuation in this group at 159.96B. The lowest valued company is HGYMF at 126.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Other Industry was -8%. For the same Industry, the average monthly price growth was -5%, and the average quarterly price growth was 4%. STXS experienced the highest price growth at 12%, while RGNT experienced the biggest fall at -42%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Other Industry was 21%. For the same stocks of the Industry, the average monthly volume growth was 3% and the average quarterly volume growth was -39%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 53
Price Growth Rating: 52
SMR Rating: 81
Profit Risk Rating: 94
Seasonality Score: 18 (-100 ... +100)
Paper Trades 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of consumer dispensing systems

Industry PharmaceuticalsOther

Industry
Containers Or Packaging
Address
265 Exchange Drive
Phone
+1 815 477-0424
Employees
14000
Web
https://www.aptar.com
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.